University of Rochester Medical Center
Pediatric Hematology-Oncology fellowship · Rochester, NY · Program website
Pediatrics residency here · Other fellowships: Neonatal-Perinatal Medicine · Pediatric Cardiology · Pediatric Critical Care Medicine · Pediatric Emergency Medicine · Pediatric Gastroenterology · Pediatric Infectious Diseases · Pediatric Pulmonology · Pediatric Nephrology
Roster not collected yet. There's no list of this program's own faculty, trainees, or papers yet. Below is University of Rochester Medicine's research in pediatric hematology-oncology, which the program shares with other departments and affiliated hospitals.
Pediatric Hematology-Oncology at University of Rochester Medicineshared by every program there, not this program's own
Institution-level: all pediatric hematology-oncology publications from University of Rochester Medicine and affiliated institutions, since 2022. Updated 2026-11-07; refreshed daily.
Works per year · * 2026 so far
Pediatric Hematology-Oncology research topics at University of Rochester Medicine
Papers in the window; each links to the list on OpenAlex.
Most cited at University of Rochester Medicine since 2024
All pediatric hematology-oncology papers there on OpenAlex
- The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023Lisa M Force et al. · The Lancet · 2025 · PubMed · cited 515
- Phase III Trial of Pirtobrutinib Versus Idelalisib/Rituximab or Bendamustine/Rituximab in Covalent Bruton Tyrosine Kinase Inhibitor–Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-321)Jeff Porter Sharman et al. · Journal of Clinical Oncology · 2025 · PubMed · cited 55
- Safety and activity of talquetamab in patients with relapsed or refractory multiple myeloma (MonumenTAL-1): a multicentre, open-label, phase 1–2 studyAjai Chari et al. · The Lancet Haematology · 2025 · PubMed · cited 130
- Symptom monitoring with electronic patient-reported outcomes during cancer treatment: final results of the PRO-TECT cluster-randomized trialEthan Basch et al. · Nature Medicine · 2025 · PubMed · cited 99
- Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ENGOT-OV26/GOG-3012 trialBradley J. Monk et al. · Annals of Oncology · 2024 · PubMed · cited 203
- Determinants of survival after first relapse of acute lymphoblastic leukemia: a Children’s Oncology Group studySusan R. Rheingold et al. · Leukemia · 2024 · PubMed · cited 91
- Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T ConsortiumMichael David Jain et al. · Journal of Clinical Oncology · 2024 · PubMed · cited 92
- Management of Fatigue in Adult Survivors of Cancer: ASCO–Society for Integrative Oncology Guideline UpdateJulienne E. Bower et al. · Journal of Clinical Oncology · 2024 · PubMed · cited 328
- Clinical Management of Patients With Relapsed/Refractory Multiple Myeloma Treated With TalquetamabAjai Chari et al. · Clinical Lymphoma Myeloma & Leukemia · 2024 · PubMed · cited 57
- Organ Preservation and Survival by Clinical Response Grade in Patients With Rectal Cancer Treated With Total Neoadjuvant TherapyHannah M. Thompson et al. · JAMA Network Open · 2024 · PubMed · cited 151
Add to your program's websitea badge, your paper list, a feed
For program directors and coordinators. Both update with the site and need no account.
<a href="https://openprograms.org/programs/university-rochester-medical-center-peds-heme-onc"><img src="https://openprograms.org/programs/university-rochester-medical-center-peds-heme-onc/badge.svg" alt="University of Rochester Medical Center Pediatric Hematology-Oncology fellowship on OpenPrograms" height="20"></a>Something wrong or missing on this page? Use the correction form below; changes show up in both.